Kayentis has announced it is forging ahead on five new eCOA service projects with Emerging BioPharma companies. The projects Kayentis is collaborating on involve phase II and III clinical studies in therapeutic areas addressing unmet needs in areas like oncology, immune disorders, and rare disea
Kayentis is a France-based digital platform that offers solutions including electronic clinical outcome assessment and clinical trial for pharmaceutical companies.